Results 61 to 70 of about 18,094 (170)
Onychomycosis and Children – A Multicenter Study
Acta Medica Bulgarica, 2015 Onychomycosis is a chronic disease caused by dermatophytes, yeasts and molds, which leads to destruction of the nail plate of the fingernails and toenails.
Zisova L. +4 more
doaj +1 more source
Health Science Reports, Volume 9, Issue 5, May 2026.ABSTRACT Background Nanotechnology has emerged as a transformative approach in dermatology, offering potential for enhanced drug delivery, targeted therapy, and improved bioavailability for various skin conditions. However, despite significant research output, translational barriers persist due to heterogeneous study designs, safety concerns, and ...
Mohammed Saleh Al‐Dhubaibi +5 more
wiley +1 more source
Metalloids: Semi as Metals yet Full of Antimicrobial Potential
ChemMedChem, Volume 21, Issue 7, 14 April 2026.Metalloids such as boron (B), silicon (Si), germanium (Ge), arsenic (As), antimony (Sb), and tellurium (Te) bridge metals and non‐metals, displaying unique chemical versatility. Recent research highlights their diverse antimicrobial and therapeutic potentials, from natural products to synthetic organic and organometallic molcules, underscoring renewed ...
Kevin Böhm +2 more
wiley +1 more source
Ultrasonographic characterization of the nails in patients with psoriasis and onychomycosis
The Egyptian Journal of Radiology and Nuclear Medicine, 2015 Objective: The study aimed at assessment of ultrasound (US) in diagnosing nail psoriasis and onychomycosis. Methods: One hundred subjects were included: the psoriatic patients group (n = 25), the onychomycosis patients group (n = 25) and the control ...
Shaymaa Muhammad Ally Essayed +3 more
doaj +1 more source
Low‐Temperature Atmospheric‐Pressure Plasma Assisted Therapy for Onychomycosis
Plasma Processes and Polymers, Volume 23, Issue 4, April 2026.This study demonstrates that argon atmospheric‐pressure plasma jet significantly enhances onychomycosis treatment by boosting drug penetration. Combined plasma–medication therapy showed superior antimicrobial efficacy against Candida albicans compared to medication alone, highlighting its potential as a safe and effective plasma‐assisted drug delivery ...
Hua‐Lin Chen +2 more
wiley +1 more source
Onychomycosis among cancer patients undergoing chemotherapy in Tehran, Iran: a cross-sectional study
Iranian Journal of MicrobiologyBackground and Objectives: Due to the persistence of residual fungal elements, onychomycosis tends to have a high recurrence rate. It is essential to determine the etiology and frequency of onychomycosis across various factors.
Fatemeh Fathi +6 more
doaj +1 more source
Prevalence of Onychomycosis by Non Dermatophyte Molds in a Tertiary Care Hospital in Kolkata , West Bengal, India [PDF]
Afro-Egyptian Journal of Infectious and Endemic DiseasesBackground and study aim: Onychomycosis is infection of dermatophytes and Candida sp, and unusually by non-dermatophyte molds (NDM). These NDM are opportunistic fungus seen in plant & soil.
Ranjan Basu +5 more
doaj +1 more source
Onychomycosis in Ceará (Northeast Brazil): epidemiological and laboratory aspects
Memorias do Instituto Oswaldo Cruz, 2005 Knowledge of epidemiological and mycological characteristics of onychomycosis has been noted by many authors as being an important tool for control of these fungal infections.
RSN Brilhante +7 more
doaj +1 more source
Retrospective Analysis of Onychomycosis Risk Factors Using the 2003-2014 National Inpatient Sample
Dermatology Practical & ConceptualIntroduction: Onychomycosis, a fungal nail infection, is associated with significant morbidity and negative impact on quality of life. Therefore, understanding associated risk factors may inform onychomycosis screening guidelines.
Vrusha Shah, Amar Desai, Shari Lipner
doaj +1 more source
Global onychomycosis management and the challenges of antifungal stewardship
Journal of Dermatological TreatmentPurpose Onychomycosis, in contrast to other routine superficial dermatophyte infections, is difficult to treat and poor outcomes are not unusual. Few guidelines for onychomycosis management have been published, and these vary considerably from region to ...
Aditya K. Gupta +9 more
doaj +1 more source